Incomplete Estrogen Suppression With Gonadotropin-Releasing Hormone Agonists May Reduce Clinical Efficacy in Premenopausal Women With Early Breast Cancer-Reference-Cited by-同舟云学术

Incomplete Estrogen Suppression With Gonadotropin-Releasing Hormone Agonists May Reduce Clinical Efficacy in Premenopausal Women With Early Breast Cancer

Published:2016-05-10 Issue:14 Volume:34 Page:1580-1583
ISSN:0732-183X
Container-title:Journal of Clinical Oncology
language:en
Short-container-title:JCO

Author:

Dowsett Mitch¹,Lønning Per E.²,Davidson Nancy E.³

Affiliation:

1. Royal Marsden Hospital, London, United Kingdom

2. University of Bergen and Haukeland University Hospital, Bergen, Norway

3. University of Pittsburgh Cancer Institute and UPMC CancerCenter, Pittsburgh, PA

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Cancer Research,Oncology

Link

https://ascopubs.org/doi/pdfdirect/10.1200/JCO.2015.62.3728

Reference27 articles.

1. Combined Treatment With Buserelin and Tamoxifen in Premenopausal Metastatic Breast Cancer: a Randomized Study

2. Vorozole results in greater oestrogen suppression than formestane in postmenopausal women and when added to goserelin in premenopausal women with advanced breast cancer

3. Zoledronic acid combined with adjuvant endocrine therapy of tamoxifen versus anastrozol plus ovarian function suppression in premenopausal early breast cancer: final analysis of the Austrian Breast and Colorectal Cancer Study Group Trial 12

4. Adjuvant Exemestane with Ovarian Suppression in Premenopausal Breast Cancer

5. Adjuvant Ovarian Suppression in Premenopausal Breast Cancer

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Selection of appropriate biomarkers to monitor effectiveness of ovarian function suppression in pre-menopausal patients with ER+ breast cancer;npj Breast Cancer;2024-01-19

2. Goserelin Ovarian Ablation Failure in Premenopausal Women With Breast Cancer;Cureus;2021-11-15

3. Systemic Therapy for Estrogen Receptor–Positive, HER2-Negative Breast Cancer;New England Journal of Medicine;2020-12-24

4. Oral GnRH Antagonist Ovarian Suppression After Escape From GnRH Agonist in Breast Cancer Patients;Clinical Breast Cancer;2020-10

5. Surgical oophorectomy or GnRH plus tamoxifen adjuvant therapy for breast cancer in low-risk premenopausal women: comparative benefits and risks;Obstetrics & Gynecology International Journal;2020-08-12